FDA Drug/Biologics Approval BLA 125504 S-002, SECUKINUMAB

FDA Drug/Biologics Approval BLA 125504 S-002, SECUKINUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125504 S-002
Company: NOVARTIS PHARMS CORP
Drug Name: COSENTYX
Active Ingredients: SECUKINUMAB
Strength: 150MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 01/21/2015
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details